Showing results (161-170 of 177) with videos related to
Sort By:
Pageof 18
Research and Practice in Thrombosis and Haemostasis|January 19, 2026
Health-related quality of life and mental health in autoimmune thrombotic thrombocytopenic purpura patients in the caplacizumab eraJulia Weisinger, Christina Tites, Laurent Gilardin, et al.Therapeutic Drug Monitoring|February 2, 2016
A Lack of Significant Effect of POR*28 Allelic Variant on Tacrolimus Exposure in Kidney Transplant RecipientsAnne-Sophie Jannot, Xavier Vuillemin, Isabelle Etienne, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 9, 2025
A longitudinal analysis of haemoglobin levels and major cardiovascular eventsLisa Le Gall, Natalia Alencar de Pinho, Jérôme Harambat, et al.Kidney International Reports|June 11, 2020
Spondyloarthritis-Associated IgA NephropathyNicolas Champtiaux, Frédéric Lioté, Khalil El Karoui, et al.Hypertension (Dallas, Tex. : 1979)|August 30, 2021
SPARTE Study: Normalization of Arterial Stiffness and Cardiovascular Events in Patients With Hypertension at Medium to Very High RiskStephane Laurent, Gilles Chatellier, Michel Azizi, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2023
Haemoglobin trajectories in chronic kidney disease and risk of major adverse cardiovascular eventsLisa Le Gall, Jérôme Harambat, Christian Combe, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|August 17, 2023
Tacrolimus Exposure Before and After a Switch From Twice-Daily Immediate-Release to Once-Daily Prolonged Release Tacrolimus: The ENVARSWITCH StudyCaroline Monchaud, Jean-Baptiste Woillard, Sabrina Crépin, et al.Critical Care Medicine|September 20, 2011
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference CenterAntoine Froissart, Marc Buffet, Agnès Veyradier, et al.Frontiers in Immunology|July 21, 2023
Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane diseasePauline Caillard, Cécile Vigneau, Jean-Michel Halimi, et al.Journal of Clinical Medicine|March 8, 2020
Severe Infection in Anti-Glomerular Basement Membrane Disease: A Retrospective Multicenter French StudyPauline Caillard, Cécile Vigneau, Jean-Michel Halimi, et al.Pageof 18